Maignan, Emmanuelle, Monique Legrand, Ilham Aboulfath, Michel Safar, and Jean-Louis Cuche. Norepinephrine kinetics in freely moving rats. Am J Physiol Endocrinol Metab 281: E726-E735, 2001.-Norepinephrine (NE) kinetics were investigated in freely moving (FM) and minimally stressed (MS) rats with the isotope dilution technique. 1) The mean NE spillover rate (NE-SOR) was 79 Ϯ 6 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , and the mean NE metabolic clearance rate (NE-MCR) 179 Ϯ 9 ml⅐ kg Ϫ1 ⅐ min Ϫ1 (n ϭ 31). Thus the NE kinetics in FM and MS rats are much faster than in human beings, probably related to a higher sympathetic drive. 2) Whether the magnitude of NE-MCR is related to the level of plasma NE concentration was investigated. No significant correlation was calculated between plasma NE concentration and NE-MCR in 31 control rats. When plasma NE concentration was varied during either acute or chronic infusion of exogenous NE, NE-MCR remained unchanged as long as animal hemodynamics were not altered. When plasma NE concentration was high enough to increase mean arterial pressure (MAP), NE-MCR was decreased. However, when MAP was increased within comparable magnitude, NE-MCR was decreased during NE and increased during epinephrine (Epi) infusion. Thus the existence of an ␣-/␤-adrenergic mechanism involved in the regulation of NE-MCR independent of known hemodynamic mechanisms is suggested.
others. The radiotracer technique provides the investigator with an estimate of what comes in plasma, NE spillover rate (NE-SOR), and what comes out, metabolic clearance rate (NE-MCR), information of a broader physiological meaning than plasma NE concentration alone. Also, it allows a more refined understanding of sympathetic activity through estimates of regional contributions, at least in humans. Thus the radioisotope dilution technique has strongly improved our understanding of sympathetic activity in humans.
The aim of the present study was to investigate the relationship between plasma catecholamine and the kinetics of NE in normotensive, freely moving rats. A three-step study was designed. 1) The physiology of NE kinetics in the rat remains poorly known; previous studies have dealt with NE kinetics in controls or in response to antihypertensive drugs in spontaneously hypertensive rats (10, 21, 22) . Our working hypothesis was to consider that NE kinetics should be in agreement with a high sympathetic drive in the rodent (28, 34, 36) . 2) Whether the capacity of the rat organism to clear NE, as judged with the NE-MCR, adapts itself to plasma NE concentration was investigated in rats given various infusion rates of exogenous NE during short (90 min) or long-lasting (7 days) periods of time. Special attention was paid to investigating the NE kinetics in the range of plasma catecholamine concentrations apparently devoid of hemodynamic effect. 3) Epinephrine (Epi) was proposed ("epinephrine hypothesis") to participate in the presynaptic regulation of the release of NE, with conflicting conclusions (1, 3, 16, 23, 24, 26, 29, 30, 33) . It was revisited in freely moving rats kept in apparently quiet conditions and given increasing doses of exogenous Epi. The effect on NE-SOR appears to be dose dependent; furthermore, on the basis of previous reports (30, 31, 33, 35) , we hypothesized a presynaptic regulation of NE release under the control of a delicate ␣ 2 -inhibition/␤ 2 -activation balance. The Epi-induced ␤ 2 -activation could become more efficient when the ␣ 2 -inhibition was partially canceled by yohimbine. Thus the rat appears to be a mammal with a high sympathetic drive and with a tight control of presynaptic regulation of NE release.
MATERIALS AND METHODS
Wistar rats (n ϭ 154; Elevage Janvier, Le Genest Saint Isles, France) were housed in individual cages and fed ad libitum 24 h/day; lights went off at 1800 and on at 0600. Previous work has shown that anesthesia can create misleading information on sympathetic activity, making inappropriate any investigation carried out on anesthetized animals (25) . All were studied in freely moving and apparently undisturbed conditions, equipped according to the following procedure.
Implantation of Catheters
All animals were anesthetized with pentobarbital sodium (60 mg/kg ip) and surgically implanted with femoral arterial and venous catheters for measurement of mean arterial pressure (MAP) and heart rate (HR) and for administration of tritiated NE, as well as other physiological or pharmacological compounds according to further-described experimental protocols. These catheters were routed subcutaneously to the back of the neck, exteriorized, and flushed regularly with sterile saline. A full week was allowed for recovery from anesthesia. At the end of the experiment, the animal was killed with an extraphysiological dose of pentobarbital sodium.
Blood Pressure and HR Recordings
The femoral artery catheter was connected to a Gould pressure processor via a pressure transducer (Gould P231 D). MAP and HR were electrically integrated on the signal of instantaneous pressure by means of a Gould DC amplifier and a Gould Biotach, respectively. Between 20 and 30 min were allowed for equilibration of the preparation.
Measurements of NE Kinetics
The isotope dilution technique described by Esler et al. (13) was used. Briefly, tritium-labeled norepinephrine ([ H]NE, 40-60 Ci/mmol, 1 mCi/ml, New England Nuclear, Boston, MA) was diluted with 500 l of 0.2 M acetic acid plus 50 l of sodium sulfite (100 mg/ml), 350 l of reduced glutathione (6 mg/ml) qsp 10 ml with 0.9% sodium chloride. ). The arterial plasma sample obtained at the end of each experiment was divided into two parts: one fraction was run according to procedures routinely used in our laboratory (Paris), whereas the other was sent to the Clinical Neuroscience Branch, National Institutes of Health (NIH), Bethesda, MD (11, 27) . One of us (E. Maignan) was kindly welcomed to run the series of samples with the HPLC procedure at NIH.
The mobile phase [50 M Na 2PO4 ⅐ H2O, 130 M EDTA, 3.6% acetonitrile, and octanesulfonic acid (48 mg/ml), adjusted to pH 3.1 with phosphoric acid] was filtered (0.22-m membrane, Millipore, Bedford, MA), degassed, and pumped through the system at 1 ml/min. It was changed daily because of the presence of tritium.
Between 0.3 and 0.8 ml of plasma samples and 20 l of infusate were mixed for 30 min with 5 mg of alumina (acid washed and stored at 100°C before use), DHBA as internal standard (2 ng), and 500 l of Tris (pH 8.6). After brief centrifugation, the supernatant was discarded, and alumina was washed twice with milli-Q water. One hundred microliters of an acid solution [0.2 M phosphoric acid-0.2 M acetic acid (5-10%)] were added to the alumina, and the mixture was vortexed for 5 min to elute the catecholamines. A second elution was performed with 50 l of the same acid solution to increase the recovery. After centrifugation, the supernatant (145 l) was transferred into microsample vials, ready for injection by the autosampler.
The collected tritiated fraction was mixed with scintillation cocktail (Ecoscint A, National Diagnostic, Atlanta, GA), and tritium content was determined using a liquid scintillation analyzer (LS3801, Beckman). A part of the infusate was counted without extraction.
The mean (ϮSE) recovery of the DHBA internal standard was 77.7 Ϯ 4.4%. Plasma concentrations of labeled and endogenous catecholamines were corrected according to the recovery of DHBA. Sensitivity of the assay was within the range of 1 and 4 pg of catecholamines measurable per milliliter of plasma. Interassay coefficients of variation, obtained using a quality control, were 4.3% for DHPG, 4.7% for NE, and 16.4% for epinephrine.
Endogenous catecholamines were measured according to a radioenzymatic assay routinely used in our laboratory (4) . NE-SOR and NE-MCR were calculated according to Esler's procedure (12) .
Experimental Protocols
Intravenous infusion of tritiated NE. Data obtained in freely moving rats given sodium chloride with or without tritiated NE are shown Table 2 . No statistically significant difference was observed. In plasma, NE was slightly raised (ϩ15%) but not significantly higher in rats given tritiated NE.
Study of NE clearance: infusions of exogenous NE. In given experimental conditions, one may wonder whether the capacity of the rat's organism to clear NE is dependent on the level of NE released and circulating in plasma. Previous reports came to differing conclusions. In humans, plasma NE concentration and NE clearance were significantly negatively correlated for Gordon et al. (17) , whereas infusion of pressor doses of NE failed to alter NE clearance for Ziegler et al. (37) ; in the rat, an apparently nonsignificant 22% increase was reported in rats given pressor doses of exogenous NE (10). Our working hypothesis was to consider that the capacity of rat's organism to clear NE could increase as long as the hemodynamic state remained unaltered. Beyond a still undefined range of plasma NE concentrations, when MAP increases, the NE-MCR may be expected to decrease through various mechanisms where cardiac output and blood flows are likely to have a major role (12) , whereas other mechanisms should not be excluded (6) . Intravenous infusion rates of exogenous NE were empirically chosen to mimic various rates of NE delivered in plasma. The first infusion rate (50 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was chosen to increase plasma NE concentration with no measurable effect on rat hemodynamics (MAP and HR). A second group of animals was given NE at 500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 . MAP was not changed, and HR was slower. In a third group of rats, exogenous NE was infused at 3,000 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 to induce a moderate hypertensive effect. Rats entering that series of experiments were randomly assigned to four groups and given either sodium chloride or exogenous NE infusion together with tritiated NE for a period of 90 min.
Because adaptation of NE-MCR might be time dependent, a second series of experiments was carried out in rats given either sodium chloride or exogenous NE (50 or 500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) infusion for a period of 7 days.
Effects of Exogenous Epi Infusion on NE Kinetics
Several years ago, it was hypothesized that Epi incorporated into nerve terminal stores could act to facilitate sympathetic neurotransmission via activation of presynaptic ␤2-adrenoreceptors (24) . Several reports have confirmed an Epidependent release of NE in humans (3, 15, 23, 26) . In the study of Kjeldsen et al. (23) , intra-arterial infusion of Epi in the human forearm was shown to increase both plasma NE concentration and forearm blood flow, suggesting a disassociation between metabolic and hemodynamic effects induced by Epi. Nonetheless, the "epinephrine hypothesis" was not always confirmed (16) . In animals, reported conclusions are conflicting. Although a pronounced facilitation of endogenous NE release by presynaptic ␤2-adrenoceptors was reported in freely moving rats (30) , and to a lesser extent in the dog heart (29), Epi or isoprenaline failed to facilitate stimulus-induced NE overflow in the isolated perfused rat kidney or in the rabbit isolated ear artery, respectively (1, 33) . Thus NE kinetics were investigated in freely moving (FM) and mildly stressed (MS) rats given exogenous Epi infusion at various rates that were chosen 1) to have no hemodynamic as well as no metabolic effect (50 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ), as judged by the lack of effect on MAP and HR as well as on plasma glucose concentration (32) ; 2) to incrementally increase plasma Epi concentration in the neighborhood of its upper physiological limit (500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) as judged by plasma Epi concentrations in exercising rats (31) while MAP was not altered; ). Rats entering that series of experiments were randomly assigned to four groups and given either sodium chloride or exogenous Epi infusion, together with tritiated NE, during 90 min.
Effect of ␣2-Antagonist Yohimbine on ␤2-Facilitation of NE Release Induced by Exogenous Epi Infusion
Several groups (30, 31, 33) have suggested the existence of a pronounced counterregulatory role of presynaptic ␣2-adrenoceptors in the rat; ␣2-adrenoceptors tonically restrain NE synthesis, release, and turnover in sympathetic nerves (35) . Further injection of the presynaptic ␣2-adrenoreceptor antagonist yohimbine in combination with infusion of the ␤2-selective agonist fenoterol into adrenalectomized rats caused an enormous increase in plasma NE (31). Thus we assumed that Epi could increase the release of NE if the ␣2-dependent inhibition was canceled, at least partially, by yohimbine. FM rats entered that series of experiments in randomized order. Three rats were given Epi (500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) alone; because results were not different from those obtained in the previous series, the two groups (8 ϩ 3) of experiments were combined. Eleven rats were given intravenous infusion of yohimbine at 5,000 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ; the yohimbine infusion rate was empirically defined to be the highest possible, not affecting MAP. Twelve rats were given a combined infusion of exogenous Epi (500 ng ⅐ kg
Statistical Analysis
Data were expressed as means Ϯ SE. NE-SOR and NE-MCR were normalized according to body weight. Differences were tested by either paired t-test or nonparametric MannWhitney test. P Ͻ 0.05 was accepted as the minimal level of significance.
RESULTS

Methodology: Pilot Study
Because alumina-extractable tritium represents a mixture of several radioactive compounds, a mixture that makes NE kinetics data unclear, a pilot study was carried out to compare data obtained according to the procedure used in "Paris" (alumina-extractable tritium and radioenzymatic method when needed) to that used in the Clinical Neuroscience Branch (NIH), which combines an HPLC analysis of the radioactivity eluted from alumina ([ 3 H]NE and [ 3 H]DHPG) with HPLC measurement of catecholamines (later on defined as "NIH"). Data obtained are shown in Table 1 .
The second column of Table 1 reports data obtained when the radioactivity, expressed in disintegrations per minute, of given [ 3 H]NE infusates was measured by direct scintillation counting in Paris and NIH. The two series should be identical; however, tritium infusion rates turned out to be 25% higher in Paris than in NIH. Whether Paris countings were contaminated by a degradation product was ruled out by data obtained in NIH: there was no difference in the radioactivity of infusates after alumina extraction compared with direct counting. Thus we have to consider that the difference was related to a difference in quench correction by the two scintillation counters. Scintillation counting carried out in Paris was used, when needed, to obtain reported data.
A statistically significant positive correlation was computed between tritium infusion rate and tritium concentration in plasma: y ϭ 516 ϩ 0.005x, P Ͻ 0.001, in 31 control rats. Thus variations in tritium infusion rates account for ϳ29.5% in variation of tritium concentration in plasma. As expected, tritium concentration measured in Paris (679 Ϯ 77 dpm/ml) was significantly higher than [ 3 H]NE measured in NIH (337 Ϯ 39 dmp/ml). Three factors accounted for that differ- Because the ratio of DHPG to NE was shown to increase when exogenous NE was infused (10), the present pilot study was also run in rats given either 500 or 3,000 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 of exogenous NE. Indeed, the percentage of radioactivity associated with [ 3 H]DHPG increased up to 10.1% during 500 and 18.9% during 3,000 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 infusion rate of exogenous NE. Thus the radioactivity associated with [ 3 H]DHPG that could be considered as small in control rats (5.6%) became substantial in rats given exogenous NE.
NE Kinetics in Resting Rats
Data obtained in a group of 31 FM and MS animals are shown in Table 2 . The mean NE-SOR was 79 Ϯ 6 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , whereas the mean NE-MCR was 179 Ϯ 9 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 . Figure 1 shows a lack of statistical correlation between plasma NE and NE-MCR.
Effects of Exogenous NE Infusions
In rats given infusion of exogenous NE, NE-SOR are not reported, because their physiological meaning is difficult to assess in such experimental conditions.
In rats given acute infusion of exogenous NE (Table  3) , the NE-MCR remained unchanged within a range of NE concentration from control to about a sixfold increase. The upper limit of that stability appears to be indicated by the slowing of HR. Beyond about six times the control level of NE concentration, an increased MAP was observed, associated with a significant decrease of NE-MCR. The statistically significant increase of plasma dopamine concentration during intravenous infusion of NE at 50 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 was unexpected; its physiological meaning remains unclear. In rats given chronic infusion (7 days) of exogenous NE, an apparent increase of the animal's general metabolism is suggested by the statistically significant decrease in body weight of those that were given either 50 or 500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 of exogenous NE. NE-MCR remained unchanged (Table 4) .
Effects of Exogenous Epi Infusions
Data obtained are shown in Table 5 . When plasma Epi concentration was increased up to ϳ3,200 pg/ml, plasma catecholamine concentrations as well as NE kinetics were not changed. When plasma Epi concentration was in the neighborhood of 20,000 pg/ml, MAP was significantly increased as expected, whereas HR was not. Both NE-SOR and NE-MCR were significantly increased, accounting for the nonsignificant increase of plasma NE concentration. Plasma dopamine concentration was significantly increased for a stillunknown reason.
Effects of Exogenous Epi Infusion in Association With Yohimbine
Results are shown in Table 6 . Data obtained during yohimbine (5,000 ng ⅐ kg Ϫ1 ⅐ min
Ϫ1
) infusion alone have to be compared with those of controls ( Table 2) . As expected, plasma NE and NE-SOR were slightly but nonsignificantly increased. Compared with preinfusion levels, MAP was not changed, whereas HR was significantly increased (ϩ32 Ϯ 6 beats/min, P Ͻ 0.05).
In rats given combined infusions of Epi with yohimbine, plasma Epi levels were not different from Epi levels measured in rats given Epi infusion alone. However, their plasma NE concentration and NE-SOR were significantly increased when compared with animals receiving either Epi or yohimbine infusion alone. NE-SOR was about three times higher in rats given Epi ϩ yohimbine compared with those given Epi alone. Changes in the NE-SOR accounted for changes in plasma NE concentration, as NE-MCR was not changed.
DISCUSSION
The present study was carried out to investigate the relationship between the level of circulating catecholamines and the kinetics of NE in normotensive FM and MS rats. The isotope dilution technique was adapted to small-sized animals, and alumina-extractable tritium was used.
Methodologies and NE Kinetics in Control Rats
Measurement of catecholamines and their metabolites remains a challenge for the investigator. Three points deserve comment. 1) Although the radioenzymatic procedure runs the sample of plasma in its orig- inal physiological equilibrium (there is no need for protein precipitation with strong acid), the HPLC procedure was developed up to the point where it has become a standard procedure. Paired comparisons of the two procedures have reported conflicting conclusions. Although plasma NE concentration was reported to be 40% higher (P Ͻ 0.001) with radioenzymatic assay (8) , it is shown to be 15% lower (P Ͻ 0.05) in the present study when compared with HPLC (Table 1) . That contradiction remains unexplained at the moment. 2) A second difference could have a potential role in discussing data obtained in the present study. The radioenzymatic procedure reports plasma concentration of DOMA in the range of 4,000 pg/ml (7); although DOMA is clearly identified by thin-layer chromatography, a nonspecific contamination cannot be ruled out.
On the other hand, HPLC indicates a plasma DOMA concentration below 10 pg/ml (10); in such a low range of plasma concentration, it is acceptable to consider that plasma DOMA is negligible from a physiological point of view. 3) Adsorption on alumina is a wellknown procedure to extract catecholamines and their metabolites (2); it is commonly accepted that only diphenolic structures are adsorbed on alumina. ]DHPG (which contributes minimally in control animals) ϩ an unknown fraction, it is understood that NE kinetics data obtained in Paris are 39.7 and 32.5% lower for NE-SOR and NE-MCR, respectively, than data obtained in NIH. Thus data on NE kinetics reported in the present study will be discussed in light of these methodological limitations.
As shown in Table 2 , intravenous infusion of radiolabeled NE had no significant effect on either circulating catecholamines or systemic hemodynamics. These data obtained in FM and MS rats (n ϭ 31) indicate that their mean NE-SOR was 79 Ϯ 6 ng⅐ kg Ϫ1 ⅐ min Ϫ1 and their mean NE-MCR was 179 Ϯ 9 ml⅐ kg Ϫ1 ⅐ min
Ϫ1
. These data, confirmed with those obtained in NIH, demonstrate a high NE turnover in the rat, with high NE-SOR and high NE-MCR, whereas plasma NE concentration is not very much different in the rat compared with humans. In healthy humans, Esler et al. (14) have reviewed several studies and concluded that venous NE-SOR ranges between 0.6 and 1.6 g/min (i.e., between 8 and 23 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 for 70 kg body wt) and the venous NE-MCR between 2.3 and 4.8 l/min (i.e., between 32 and 68 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 for 70 kg body wt). Our data on NE kinetics obtained in FM and MS rats suggest a high sympathetic drive in the rodent, as already suggested (28, 34, 36) .
Clearance of NE
The concept of clearance was developed by renal physiologists in the early 1940s to define the volume of plasma cleared from a given compound by a unit of time. It was extended by endocrinologists to cover the whole series of mechanisms that participate in the clearing process of a given hormonal agent. The concept of metabolic clearance has been applied to circulating NE (10, 12, 14) . Besides neuronal reuptake, known to have a predominant role in NE catabolism, several other mechanisms (as distinct from urinary excretion, protein binding, platelet conjugation, etc.) are assumed to have a role in the MCR of NE. Whether that metabolic process can be activated by an increased level of plasma NE is not clear. In humans, plasma NE concentration and MCR were reported to be negatively correlated (17) , although this was not confirmed (37) , whereas in the rat, NE clearance tended to increase during infusion of a pressor dose of exogenous NE (10). Our working hypothesis was to consider that the capacity of the rat organism to clear NE could increase as long as the hemodynamic state remained unaltered. Three series of data are reported. Figure 1 shows a lack of significant correlation between plasma NE and NE-MCR in 31 FM and MS rats; it suggests that the whole capacity of Wistar rats to clear NE is independent of plasma NE level, at least in resting conditions. A second series of experiments was carried out in rats given exogenous NE infusion to set up plasma NE concentrations at various levels. In acute conditions (Table 3) , the NE-MCR remained unchanged when plasma NE was increased up to ϳ2,500 pg/ml, concentrations measured in the rat during swimming exercise (31) . This is in agreement with previously reported work. Careful examination of the data of Eisenhofer et al. (10) reveals no apparent change in either DHPG or MHPG concentrations in rats given exogenous NE infusion when plasma NE remained Ͻ2,000-3,000 pg/ml. A step further, we suspected that activation of the NE-MCR could be time dependent, and exogenous NE was chronically infused for 7 days, with no effect on NE-MCR (Table 4) . Thus the whole capacity of the rat organism to clear NE is not increased when plasma NE is experimentally increased as long as the hemodynamic state is not altered. Nonetheless, we previously reported a statistically significant correlation between arterial concentration and urinary excretion of NE in the dog (5) . Whether the isotope dilution technique is not sensitive enough to identify small variations of NE-MCR should be considered. In the third series of experiments, plasma NE was increased in such a way that MAP was increased (Table 3) , and NE-MCR was shown to be significantly reduced. A first interpretation is to consider that hemodynamic changes account for the decreased NE-MCR: either a decrease of cardiac output (12), a reduction of peripheral blood flow (14) , or both. However, it deserves further comment. When plasma NE is experimentally increased, especially when it counterbalances the NE synaptic-plasma concentration gradient, NE stimulates both postsynaptic mechanisms, leading to an increase of MAP and presynaptic neuronal uptake, leading to a greater activation of the deamination pathway to form DHPG. Table  1 shows a significant increase of DHPG concentration in rats given exogenous NE at 3,000 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , with a significant increase of [ 3 H]DHPG, and a 36.7% increase (P Ͻ 0.06) of alumina-extractable tritium. Thus the neuronal component of the NE-MCR, at least, was stimulated, although its effect on the whole capacity of rat's organism to clear NE, as measured by the isotope dilution technique, was apparently overwhelmed by NE-induced hemodynamic effects.
Epinephrine Hypothesis Revisited
Several years ago, Majewski (24) hypothesized that Epi incorporated into sympathetic neuronal stores could act to facilitate sympathetic neurotransmission via activation of presynaptic ␤ 2 -adrenoceptors. Although several reports in humans demonstrated that experimentally increased plasma Epi concentration tends to increase the release of NE (3, 23, 26) , it was not always confirmed (16) . Data obtained in animals are even less clear (1, 29, 30, 33) . The epinephrine hypothesis was revisited in FM rats assumed to be in resting conditions and with special attention being paid to the level of circulating Epi. Our results (Table  5) show that NE-SOR remained unchanged when plasma Epi concentration was increased to ϳ3,200 pg/ml. When plasma Epi reached a very high level of concentration (ϳ20,000 pg/ml), two effects were observed. 1) The NE-SOR was significantly increased, suggesting that the epinephrine hypothesis is concentration dependent in the rat, revealed by the upper range of plasma Epi levels only. From a physiological point of view, one may wonder whether the increased MAP induced by high Epi concentrations represents a direct activation of adrenergic receptors leading to vasoconstriction of various vascular beds (20) , an indirect activation of NE release through presynaptic ␤ 2 -receptors, or both. 2) High Epi concentration triggered an increase of NE-MCR, accounting for the nonsignificant increase of plasma NE concentration. That effect cannot be explained at the moment; nonetheless, it leads to extending one's view on the regulation of NE-MCR. So far, hemodynamic modifications (cardiac output or vascular blood flows) have been thought to have a predominant role in the regulation of the NE-MCR (14) . Accordingly, the increase of MAP induced by the high infusion rate of exogenous NE could have accounted for the decrease of NE-MCR (Table 3) . However, the comparable increase in MAP induced by the high infusion rate of exogenous Epi is shown to be associated with an increase of NE-MCR (Table 5) . Thus the hemodynamic factors involved in the regulation of NE-MCR in the rat can be overwhelmed by mechanisms likely to be of ␤-adrenergic type. Thus an ␣-/␤-adrenergic equilibrium seems to have a role in the regulation of NE clearance in the rat, as already suggested in human beings (6) .
The epinephrine hypothesis was further investigated in the lower range of plasma Epi concentrations not having, by themselves, an effect on NE-SOR ( Table  5 ). The presynaptic membrane presents, apparently, structural features sensitive to ␤ 2 -adrenergic stimuli, leading to a facilitation of the release of NE and ␣ 2 -adrenoceptors that have a counterregulatory role, a counterregulation that appears to be predominant in the rat (29, 30, 32, 34) . We have speculated on the existence of a delicate presynaptic regulation of the release of NE on the basis of an ␣-/␤-adrenergic equilibrium. Such an equilibrium could be species dependent; the ␣-component could be much more predominant in the rat, accounting for a much higher Epi concentration (Table 5 ) than in humans (22) , to trigger an increase of NE release. If so, it could be swung toward a predominant ␤-component by architectural reordering of the presynaptic membrane with an ␣ 2 -adrenoreceptor inhibitor, yohimbine, for example. Our results support such a working hypothesis. A 500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 infusion rate of Epi, which had no effect by itself on the NE-SOR (Table 6) , increased it when infused in association with yohimbine (Fig. 2) . Thus, besides a faster NE kinetics, the rat presents a quantitatively different regulation of the presynaptic component of the NE release.
In summary, the present work was carried out to study the relationship between plasma catecholamine and the NE kinetics in the rat. 1) In freely moving rats, likely to be at rest, mean NE-SOR and NE-MCR were both much higher values than were previously re- ported in humans, in agreement with a strong sympathetic activity in the rodent. 2) Several lines of results tend to demonstrate that the NE-MCR is independent of plasma NE concentration as long as the hemodynamic state is not altered. When MAP is increased during infusion of exogenous NE, NE-MCR was decreased, suggesting a predominant role for hemodynamic factors in the control of NE-MCR. 3) Nonetheless, besides the hemodynamic, another mechanism should be considered. The NE-MCR appears also under the control of an ␣-/␤-adrenergic equilibrium, because for a comparable hypertensive effect, NE-MCR was decreased during NE and increased during Epi infusion. 4) The epinephrine hypothesis was revisited and was shown to be concentration dependent, revealed only at very high plasma Epi concentration. 5) A second epinephrine hypothesis is proposed: Epi can reveal a stimulating effect on NE-SOR, even at low plasma concentration, when presynaptic ␣ 2 -adrenoceptors are partially inhibited by yohimbine.
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